DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma - PubMed (original) (raw)
. 2007 Mar 30;355(1):72-7.
doi: 10.1016/j.bbrc.2007.01.121. Epub 2007 Jan 30.
Affiliations
- PMID: 17292327
- DOI: 10.1016/j.bbrc.2007.01.121
DLC-1, a GTPase-activating protein for Rho, is associated with cell proliferation, morphology, and migration in human hepatocellular carcinoma
Tai Young Kim et al. Biochem Biophys Res Commun. 2007.
Abstract
DLC-1 (deleted in liver cancer-1) is a tumor suppressor gene for hepatocellular carcinoma and other cancers. To characterize its functions, we constructed recombinant adenovirus encoding the wild-type DLC-1 and examined its effects on behaviors of a hepatocellular carcinoma cell line (SNU-368), which does not express DLC-1. Here, we found that restoration of DLC-1 expression in the SNU-368 cells caused an inhibition of cell proliferation with an increase of a subG1 population. Furthermore, DLC-1 overexpression induced disassembly of stress fibers and extensive membrane protrusions around cells on laminin-1. DLC-1 overexpression also inhibited cell migration and dephosphorylated focal adhesion proteins such as focal adhesion kinase (FAK), Cas (p130Cas; Crk-associated substrate), and paxillin. These observations suggest that DLC-1 plays important roles in signal transduction pathway regulating cell proliferation, cell morphology, and cell migration by affecting Rho family GTPases and focal adhesion proteins.
Similar articles
- Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC, Lo SH. Liao YC, et al. Int J Biochem Cell Biol. 2008;40(5):843-7. doi: 10.1016/j.biocel.2007.04.008. Epub 2007 Apr 20. Int J Biochem Cell Biol. 2008. PMID: 17521951 Free PMC article. Review. - Overexpression of DLC-1 induces cell apoptosis and proliferation inhibition in the renal cell carcinoma.
Zhang T, Zheng J, Jiang N, Wang G, Shi Q, Liu C, Lu Y. Zhang T, et al. Cancer Lett. 2009 Sep 28;283(1):59-67. doi: 10.1016/j.canlet.2009.03.025. Epub 2009 Apr 19. Cancer Lett. 2009. PMID: 19380190 - Rho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinoma.
Wong CM, Yam JW, Ching YP, Yau TO, Leung TH, Jin DY, Ng IO. Wong CM, et al. Cancer Res. 2005 Oct 1;65(19):8861-8. doi: 10.1158/0008-5472.CAN-05-1318. Cancer Res. 2005. PMID: 16204057 - [Relationship between DLC-1 expressions and metastasis in hepatocellular carcinoma].
Song LJ, Ye SL, Wang KF, Weng YQ, Liang CM, Sun RX, Zhao Y, Liu YK, Tang ZY. Song LJ, et al. Zhonghua Gan Zang Bing Za Zhi. 2005 Jun;13(6):428-31. Zhonghua Gan Zang Bing Za Zhi. 2005. PMID: 15975276 Chinese. - The Role of Tumor Suppressor DLC-1: Far From Clear.
Liu X, Pan YJ, Zheng JN, Pei DS. Liu X, et al. Anticancer Agents Med Chem. 2017;17(7):896-901. doi: 10.2174/1871520616666160907142754. Anticancer Agents Med Chem. 2017. PMID: 27604574 Review.
Cited by
- Curcumin inhibits the growth of triple-negative breast cancer cells by silencing EZH2 and restoring DLC1 expression.
Zhou X, Jiao D, Dou M, Zhang W, Lv L, Chen J, Li L, Wang L, Han X. Zhou X, et al. J Cell Mol Med. 2020 Sep;24(18):10648-10662. doi: 10.1111/jcmm.15683. Epub 2020 Jul 28. J Cell Mol Med. 2020. PMID: 32725802 Free PMC article. - Detection and Clinical Significance of DLC1 Gene Methylation in Serum DNA from Colorectal Cancer Patients.
Wu PP, Zou JH, Tang RN, Yao Y, You CZ. Wu PP, et al. Chin J Cancer Res. 2011 Dec;23(4):283-7. doi: 10.1007/s11670-011-0283-0. Chin J Cancer Res. 2011. PMID: 23359753 Free PMC article. - Deleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liver.
Liao YC, Lo SH. Liao YC, et al. Int J Biochem Cell Biol. 2008;40(5):843-7. doi: 10.1016/j.biocel.2007.04.008. Epub 2007 Apr 20. Int J Biochem Cell Biol. 2008. PMID: 17521951 Free PMC article. Review. - Role of DLC1 tumor suppressor gene and MYC oncogene in pathogenesis of human hepatocellular carcinoma: potential prospects for combined targeted therapeutics (review).
Zimonjic DB, Popescu NC. Zimonjic DB, et al. Int J Oncol. 2012 Aug;41(2):393-406. doi: 10.3892/ijo.2012.1474. Epub 2012 May 10. Int J Oncol. 2012. PMID: 22580498 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials
Miscellaneous